查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1667933

頸椎病診斷和治療市場 - 全球行業規模、佔有率、趨勢、機會和預測，按診斷、按產品類型、按配銷通路、按地區和競爭進行細分，2020-2030 年

Cervical Spondylosis Diagnosis And Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Product Type, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球頸椎病診斷和治療市場價值為 64.3 億美元，預計到 2030 年將達到 95.2 億美元，預測期內複合年成長率為 6.72%。全球頸椎病診斷和治療市場的主要推動因素是頸椎病患病率的上升，尤其是在老年人口和久坐生活方式的人中。人們對該疾病的認知不斷提高，加上 MRI 和 CT 掃描等診斷技術的進步，改善了早期發現和治療結果。對物理治療、藥物和微創手術等非侵入性治療方案的需求不斷成長，促進了市場擴張。先進手術技術的發展和術後護理的改善正在提高治療效果和患者的康復。生物製劑和再生醫學的創新以及對個人化醫療的日益關注，有望為頸椎病提供更有針對性和更有效的治療選擇，從而推動市場的成長。

市場概況
預測期 2026-2030
2024 年市場規模 64.3 億美元
2030 年市場規模 95.2 億美元
2025-2030 年複合年成長率 6.72％
成長最快的領域 磁振造影
最大的市場 北美洲

主要市場促進因素

頸椎病患病率不斷上升

主要市場挑戰

治療費用高昂

主要市場趨勢

再生醫學日益受到關注

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球頸椎病變診斷與治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 根據診斷（影像學檢查、頸部 X 光、MRI、CT 脊髓造影、神經功能測試、肌電圖和神經傳導研究）
    • 依產品類型（藥品、醫療器材和手術器材）
    • 按配銷通路（醫院藥房、零售藥房和網路藥房）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美頸椎病診斷與治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲頸椎病診斷與治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太頸椎病診斷與治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲頸椎病診斷與治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲頸椎病診斷與治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如果有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 27676

Global Cervical Spondylosis Diagnosis And Treatment Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 9.52 Billion by 2030 with a CAGR of 6.72% during the forecast period. The global cervical spondylosis diagnosis and treatment market is primarily driven by the rising prevalence of cervical spondylosis, particularly among the aging population and individuals with sedentary lifestyles. Increased awareness of the condition, coupled with advances in diagnostic technologies such as MRI and CT scans, has improved early detection and treatment outcomes. The growing demand for non-invasive treatment options, including physical therapy, medications, and minimally invasive surgeries, is contributing to market expansion. The development of advanced surgical techniques and improved post-operative care are enhancing treatment effectiveness and patient recovery. Innovations in biologics and regenerative medicine, along with an increasing focus on personalized healthcare, are expected to fuel growth in the market by providing more targeted and effective treatment options for cervical spondylosis.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.43 Billion
Market Size 2030USD 9.52 Billion
CAGR 2025-20306.72%
Fastest Growing SegmentMRI
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Cervical Spondylosis

The rising prevalence of cervical spondylosis is one of the primary factors driving the global market. Cervical spondylosis is more common in individuals over the age of 40, with its incidence increasing with age due to the natural wear and tear of the cervical spine. As global life expectancy rises, the elderly population is expected to grow significantly, contributing to a higher number of cervical spondylosis cases. Most individuals with spondylotic changes in the cervical spine, as seen on radiographic imaging, remain asymptomatic. However, approximately 25% of those under the age of 40, 50% of individuals over 40, and 85% of people over 60 show signs of degenerative changes. The most commonly affected vertebral levels are C6-C7, followed by C5-C6. Symptomatic cervical spondylosis typically manifests as neck pain. In the general population, the point prevalence of neck pain ranges from 0.4% to 41.5%, the 1-year incidence ranges from 4.8% to 79.5%, and lifetime prevalence can be as high as 86.8%.

Key Market Challenges

High Treatment Costs

One of the primary challenges in the cervical spondylosis diagnosis and treatment market is the high cost of treatment. Advanced diagnostic techniques such as MRI and CT scans, as well as sophisticated surgical interventions, can be prohibitively expensive, especially in low and middle-income countries. Minimally invasive surgeries, stem cell therapies, and other innovative treatment options, while highly effective, are often costly and may not be affordable for many patients. The high treatment costs place a significant burden on healthcare systems, patients, and insurance providers. Even in regions with robust healthcare infrastructure, the financial strain on patients can deter them from seeking timely treatment, which could lead to worsened health outcomes. This economic barrier to access is a challenge that hinders broader adoption of advanced treatments, especially in developing regions.

Key Market Trends

Rising Focus on Regenerative Medicine

Regenerative medicine is an emerging field that is driving significant growth in the cervical spondylosis market. This field includes the use of biologics such as stem cell therapy, platelet-rich plasma (PRP) injections, and growth factor therapies, all of which are being explored as potential treatments for cervical spondylosis. Stem cell therapy, in particular, holds great promise for patients with severe disc degeneration by promoting the regeneration of damaged tissues and encouraging the healing of spinal discs. PRP therapy involves the use of a patient's own blood platelets to promote healing and reduce inflammation in the affected cervical area. Regenerative medicine offers a more natural and minimally invasive alternative to traditional surgery, providing new hope for patients who are not candidates for more invasive procedures. As research and clinical trials continue to explore the efficacy of these treatments, regenerative medicine is expected to play an increasingly important role in managing cervical spondylosis, driving the demand for related therapies and treatments in the global market.

Key Market Players

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

Report Scope:

In this report, the Global Cervical Spondylosis Diagnosis And Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cervical Spondylosis Diagnosis And Treatment Market, By Diagnosis:

  • Imaging Tests
  • Neck X-ray
  • MRI
  • CT Myelography
  • Nerve Function Tests
  • Electromyography
  • Nerve Conduction Study

Cervical Spondylosis Diagnosis And Treatment Market, By Product Type:

  • Medications
  • Medical Devices
  • Surgical Instruments

Cervical Spondylosis Diagnosis And Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Cervical Spondylosis Diagnosis And Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cervical Spondylosis Diagnosis And Treatment Market.

Available Customizations:

Global Cervical Spondylosis Diagnosis And Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, and Nerve Conduction Study)
    • 5.2.2. By Product Type (Medications, Medical Devices, and Surgical Instruments)
    • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Diagnosis
    • 6.2.2. By Product Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Diagnosis
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Diagnosis
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Diagnosis
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Diagnosis
    • 7.2.2. By Product Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Diagnosis
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Diagnosis
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Diagnosis
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Diagnosis
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Diagnosis
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Diagnosis
    • 8.2.2. By Product Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Diagnosis
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Diagnosis
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Diagnosis
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Diagnosis
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Diagnosis
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Distribution Channel

9. South America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Diagnosis
    • 9.2.2. By Product Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Diagnosis
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Diagnosis
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Diagnosis
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Diagnosis
    • 10.2.2. By Product Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Diagnosis
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Diagnosis
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Diagnosis
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Novartis AG
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Merck & Co. Inc.
  • 14.3. Bayer AG
  • 14.4. Abbott Laboratories Inc.
  • 14.5. Ortho Bracing
  • 14.6. Medtronic Plc
  • 14.7. Stryker Corporation
  • 14.8. B. Braun SE
  • 14.9. DJO, LLC
  • 14.10. Aspen Medical Products, LLC

15. Strategic Recommendations

16. About Us & Disclaimer